Hydronephrosis Market Size, Share, Growth, and Industry Analysis, By Types (Surgical Treatment, Drug Treatment, ), By Applications (Hospital, Clinic, Ambulatory Surgery Centre, ) , and Regional Insights and Forecast to 2035

Hydronephrosis Market Size

The Global Hydronephrosis Market size was valued at USD 233.85 Million in 2025 and is projected to reach USD 264.95 Million in 2026. The market is further expected to grow to USD 300.19 Million in 2027 and reach USD 815.14 Million by 2035, exhibiting a CAGR of 13.3% during the forecast period from 2026 to 2035. Rising kidney disorder cases, increasing urinary tract blockage conditions, and growing use of advanced diagnostic imaging systems are supporting market expansion. More than 58% of healthcare providers are increasing focus on early kidney disease diagnosis, while nearly 46% of hospitals are improving minimally invasive treatment facilities for hydronephrosis patients.

The US Hydronephrosis Market is showing strong growth due to increasing awareness about kidney health and rising adoption of advanced urology treatment systems. Nearly 62% of hospitals across the country are improving robotic-assisted kidney surgery services for better patient recovery. Around 54% of healthcare providers are increasing investment in imaging technologies for faster urinary obstruction diagnosis. More than 48% of patients prefer minimally invasive procedures because of lower pain and shorter hospital stays. The growing elderly population and increasing obesity-linked kidney disorders are also supporting steady market demand across the United States.

Key Findings

• Market Size: Global Hydronephrosis Market reached USD 233.85 Million in 2025, USD 264.95 Million in 2026, and USD 815.14 Million by 2035 with 13.3% CAGR.
• Growth Drivers: Nearly 63% increase in early kidney screening programs and 49% rise in minimally invasive procedures are driving market demand globally.
• Trends: Around 58% of hospitals adopted advanced imaging systems while 44% increased robotic-assisted kidney surgery procedures for faster patient recovery.
• Key Players: NephroGenex, Allergan, Amgen, Sanofi, Novartis & more.
• Regional Insights: North America holds 38% share, Europe 29%, Asia-Pacific 24%, and Middle East & Africa 9% with expanding kidney care infrastructure.
• Challenges: Nearly 36% of healthcare facilities face imaging equipment shortages, while 33% report delays caused by limited skilled nephrology professionals globally.
• Industry Impact: Around 52% of hospitals improved diagnostic services and 41% expanded nephrology departments to manage increasing urinary obstruction patient volumes.
• Recent Developments: Nearly 47% of companies expanded kidney care research programs while 39% improved AI-supported diagnostic technologies for hydronephrosis management.

The Hydronephrosis Market is gaining attention because of the growing focus on kidney disease prevention and advanced patient monitoring systems. Nearly 57% of healthcare providers are increasing routine urinary tract screening programs to support early-stage diagnosis. Portable ultrasound device adoption has increased by approximately 42% across specialty clinics and emergency care centers. Around 35% of hospitals are integrating digital patient monitoring systems for better treatment tracking and recovery management. Rising awareness regarding chronic kidney complications and increasing preference for non-invasive procedures continue to support long-term market expansion globally.

Hydronephrosis Market Trends

The Hydronephrosis Market is growing due to the rising number of kidney-related disorders, urinary tract blockage cases, and increasing awareness about early diagnosis. More than 35% of urinary obstruction cases are linked with hydronephrosis conditions, while around 40% of patients with severe kidney stone problems develop swelling in the kidneys. Hospital screening programs for kidney diseases have increased by nearly 45%, helping doctors detect hydronephrosis at an earlier stage. Around 52% of urology departments are now using advanced imaging tools for faster diagnosis and treatment planning. The use of minimally invasive surgeries for hydronephrosis treatment has increased by nearly 48%, reducing hospital stays and recovery time.

Pediatric hydronephrosis cases account for approximately 30% of total diagnosed patients, which is increasing the demand for neonatal and child kidney care services. Nearly 55% of healthcare providers now prefer ultrasound-based diagnosis due to its high accuracy and non-invasive nature. Demand for robotic-assisted urology procedures has increased by over 32% because patients prefer safer and faster procedures. In addition, more than 47% of healthcare centers are investing in advanced kidney monitoring technologies. The Hydronephrosis Market is also supported by the rising elderly population, as nearly 60% of chronic urinary obstruction cases are seen in older adults. Increasing lifestyle disorders, diabetes, and obesity are further contributing to the demand for hydronephrosis diagnosis and treatment solutions worldwide.

Hydronephrosis Market Dynamics

OPPORTUNITY

"Expansion of Advanced Diagnostic Imaging in Kidney Care"

The Hydronephrosis Market is creating strong opportunities through the growing use of advanced diagnostic imaging systems in hospitals and specialty clinics. More than 58% of kidney disease diagnoses are now supported by ultrasound and CT scan technologies. Around 46% of healthcare providers are increasing investment in AI-supported imaging systems to improve early-stage hydronephrosis detection. Portable ultrasound device adoption has increased by nearly 39%, especially in emergency care centers and rural hospitals. Nearly 44% of patients prefer non-invasive kidney diagnostic procedures, creating higher demand for imaging-based diagnosis. The rise in telehealth consultations for urology care has also increased by over 28%, helping patients receive faster medical support and improving the growth potential of the Hydronephrosis Market.

DRIVERS

"Rising Demand for Early Kidney Disorder Treatment"

The increasing focus on early kidney disease treatment is a major driver in the Hydronephrosis Market. Nearly 63% of urologists recommend early hydronephrosis screening for patients with urinary blockage symptoms. Kidney stone cases linked with hydronephrosis have increased by approximately 41%, driving demand for better treatment methods. Around 50% of hospitals are expanding urology departments due to the rising number of kidney-related admissions. Minimally invasive procedures for urinary obstruction treatment have grown by almost 49%, improving patient recovery rates. In addition, more than 37% of patients now choose robotic-assisted surgeries because of lower surgical risks and shorter hospital stays, which is supporting continuous growth in the Hydronephrosis Market.

RESTRAINTS

"Limited Awareness and Delayed Diagnosis in Developing Areas"

One of the key restraints in the Hydronephrosis Market is the lack of awareness about kidney swelling symptoms in low-income and rural regions. Nearly 42% of patients delay medical consultation because early hydronephrosis symptoms are often ignored. Around 36% of healthcare facilities in developing areas still lack advanced imaging systems required for accurate diagnosis. Late-stage diagnosis is seen in approximately 33% of severe hydronephrosis patients, leading to higher complications and treatment difficulties. In addition, nearly 29% of patients avoid regular kidney screening due to limited healthcare access and high medical procedure concerns. These factors continue to slow the overall growth of the Hydronephrosis Market in several regions.

CHALLENGE

"Rising Treatment Complexity and Surgical Risks"

The Hydronephrosis Market faces major challenges due to the increasing complexity of kidney surgeries and treatment procedures. Nearly 31% of severe hydronephrosis cases require multiple treatment methods, increasing the burden on healthcare systems. Post-surgical complications are reported in around 18% of advanced urinary obstruction surgeries, creating concerns among patients. More than 40% of hospitals report shortages of trained urology specialists for complex kidney procedures. In addition, around 27% of patients experience treatment delays because of long waiting periods for specialized diagnostic testing. The growing need for advanced surgical equipment and skilled professionals is making treatment management more difficult, creating operational challenges for healthcare providers in the Hydronephrosis Market.

Segmentation Analysis

The Hydronephrosis Market is segmented by type and application, with increasing demand for advanced kidney care solutions supporting all segments. The Global Hydronephrosis Market size was USD 233.85 Million in 2025 and is projected to touch USD 264.95 Million in 2026 to USD 815.14 Million by 2035, exhibiting a CAGR of 13.3% during the forecast period. Surgical treatment remains highly preferred due to the growing number of severe urinary obstruction cases, while drug treatment demand is increasing because of early-stage disease management. Hospitals continue to account for a major share due to strong patient inflow and availability of advanced diagnostic equipment. Clinics and ambulatory surgery centres are also expanding rapidly because nearly 48% of patients now prefer shorter treatment procedures and faster discharge facilities. More than 55% of healthcare providers are improving kidney disease screening services, which is supporting growth across all Hydronephrosis Market segments globally.

By Type

Surgical Treatment

Surgical treatment holds a major share in the Hydronephrosis Market due to the rising number of severe kidney blockage and urinary obstruction cases. Nearly 62% of patients with advanced hydronephrosis conditions require surgical procedures for long-term recovery. Minimally invasive surgeries have increased by around 46% because of lower pain levels and faster recovery periods. Robotic-assisted kidney surgeries are also growing steadily, with adoption rates increasing by approximately 34% among specialized urology centers. Hospitals continue to improve surgical success rates through advanced imaging support and precision-based treatment systems.

Surgical Treatment held the largest share in the Hydronephrosis Market, accounting for USD 142.64 Million in 2025, representing 61% of the total market. This segment is expected to grow at a CAGR of 13.7% from 2025 to 2035, driven by rising urinary obstruction cases, growing adoption of robotic surgeries, and higher patient preference for long-term treatment solutions.

Drug Treatment

Drug treatment is growing steadily in the Hydronephrosis Market due to increasing diagnosis of early-stage kidney swelling and urinary tract infections. Nearly 44% of patients with mild hydronephrosis conditions prefer medication-based management before surgical intervention. Anti-inflammatory and infection-control drugs are widely prescribed, while approximately 39% of healthcare professionals recommend combined drug therapy for symptom reduction. The increasing awareness regarding preventive kidney care and regular medical monitoring is also helping this segment expand across hospitals and specialty clinics.

Drug Treatment accounted for USD 91.21 Million in 2025, representing 39% of the total Hydronephrosis Market share. This segment is projected to grow at a CAGR of 12.8% from 2025 to 2035, supported by increasing awareness about early kidney care, higher prescription rates, and growing preference for non-surgical treatment options.

By Application

Hospital

Hospitals account for a large share in the Hydronephrosis Market due to the availability of advanced diagnostic imaging systems, skilled urologists, and emergency kidney care services. Nearly 68% of hydronephrosis procedures are performed in hospitals because of better treatment infrastructure. Around 53% of kidney obstruction patients prefer hospitals for complex surgical procedures and post-treatment care. Hospitals are also improving robotic-assisted treatment capabilities and expanding specialized nephrology departments to handle rising patient admissions.

Hospital held the largest share in the Hydronephrosis Market, accounting for USD 119.26 Million in 2025, representing 51% of the total market. This segment is expected to grow at a CAGR of 13.5% from 2025 to 2035, driven by increasing patient admissions, advanced treatment facilities, and rising demand for specialized kidney care services.

Clinic

Clinics are becoming an important application segment in the Hydronephrosis Market because of increasing demand for quick consultation and outpatient kidney care services. Nearly 41% of patients with mild urinary disorders prefer clinics for routine diagnosis and follow-up treatment. Advanced ultrasound systems in specialty clinics have increased by approximately 37%, helping improve early disease detection. The shorter waiting time and lower treatment burden are also encouraging more patients to seek treatment through clinics.

Clinic accounted for USD 70.16 Million in 2025, representing 30% of the total Hydronephrosis Market share. This segment is projected to grow at a CAGR of 12.9% from 2025 to 2035, supported by rising outpatient visits, improved diagnostic services, and growing awareness regarding early kidney disorder management.

Ambulatory Surgery Centre

Ambulatory surgery centres are witnessing growing demand in the Hydronephrosis Market due to faster discharge services and increasing preference for minimally invasive procedures. Nearly 36% of patients undergoing kidney-related procedures now prefer ambulatory surgery centres because of lower hospital stay duration. Around 32% of healthcare providers are expanding same-day surgical treatment facilities to reduce operational burden. The use of advanced laparoscopic procedures is also increasing steadily across ambulatory care centres.

Ambulatory Surgery Centre accounted for USD 44.43 Million in 2025, representing 19% of the total Hydronephrosis Market share. This segment is expected to grow at a CAGR of 13.1% from 2025 to 2035, driven by increasing demand for outpatient surgeries, faster recovery services, and rising adoption of minimally invasive kidney treatment procedures.

Hydronephrosis Market Regional Outlook

The Global Hydronephrosis Market size was USD 233.85 Million in 2025 and is projected to touch USD 264.95 Million in 2026 to USD 815.14 Million by 2035, exhibiting a CAGR of 13.3% during the forecast period. North America holds the largest regional share due to advanced kidney care systems and high awareness levels. Europe continues to expand because of rising elderly populations and improved diagnostic services. Asia-Pacific is witnessing rapid growth because of increasing healthcare investments and higher kidney disease cases. Middle East & Africa is gradually improving with better access to urology treatment services. North America accounts for 38% market share, Europe represents 29%, Asia-Pacific holds 24%, and Middle East & Africa contributes 9% of the global Hydronephrosis Market.

North America

North America continues to lead the Hydronephrosis Market due to strong healthcare infrastructure and growing adoption of advanced kidney treatment technologies. Nearly 64% of hospitals in the region use robotic-assisted surgical systems for complex urology procedures. Around 58% of kidney disease screenings are performed through advanced imaging technologies such as ultrasound and CT scans. The rising elderly population and increasing obesity-related kidney disorders are also contributing to market expansion. More than 49% of healthcare providers are investing in minimally invasive procedures to improve recovery outcomes. Strong insurance coverage and better patient awareness continue to support high treatment rates across the region.

North America accounted for USD 100.68 Million in 2026, representing 38% of the global Hydronephrosis Market share, supported by strong healthcare facilities, high surgical adoption rates, and increasing early kidney disease diagnosis.

Europe

Europe is witnessing stable growth in the Hydronephrosis Market because of increasing healthcare awareness and growing investment in kidney disease treatment. Nearly 55% of urology departments across Europe are expanding diagnostic imaging capabilities for faster disease detection. Around 43% of patients prefer minimally invasive kidney surgeries because of lower recovery time and reduced complications. Government healthcare programs focused on chronic kidney disease screening are also increasing patient diagnosis rates. More than 39% of specialty hospitals are improving nephrology care units to manage rising urinary obstruction cases. The growing aging population remains a key factor driving regional market demand.

Europe accounted for USD 76.84 Million in 2026, representing 29% of the global Hydronephrosis Market share, driven by increasing healthcare investments, higher screening rates, and rising adoption of advanced kidney care technologies.

Asia-Pacific

Asia-Pacific is experiencing rapid expansion in the Hydronephrosis Market due to rising healthcare spending and growing awareness about kidney disorders. Nearly 52% of healthcare facilities in urban areas are improving diagnostic imaging systems for urinary tract disease management. Increasing diabetes and obesity cases are contributing to a higher number of kidney-related complications across the region. Around 47% of hospitals are expanding urology departments to handle growing patient volumes. Medical tourism for affordable kidney surgeries is also increasing steadily in several Asia-Pacific countries. Rising government support for healthcare infrastructure development is further improving treatment accessibility.

Asia-Pacific accounted for USD 63.59 Million in 2026, representing 24% of the global Hydronephrosis Market share, supported by growing patient populations, expanding healthcare facilities, and rising adoption of advanced surgical procedures.

Middle East & Africa

Middle East & Africa is gradually strengthening its position in the Hydronephrosis Market because of improving healthcare infrastructure and increasing investment in specialized kidney treatment centers. Nearly 35% of hospitals in the region are upgrading imaging technologies to improve urinary disorder diagnosis. Around 29% of healthcare providers are expanding nephrology and urology departments to manage increasing kidney disease cases. Government healthcare initiatives are helping improve awareness regarding early-stage urinary obstruction treatment. More than 26% of patients are now seeking minimally invasive procedures for kidney-related disorders due to faster recovery benefits. Rising healthcare access in urban areas and improving specialist availability continue to support market growth across the region.

Middle East & Africa accounted for USD 23.84 Million in 2026, representing 9% of the global Hydronephrosis Market share, driven by improving medical infrastructure, rising patient awareness, and increasing demand for advanced kidney treatment services.

List of Key Hydronephrosis Market Companies Profiled

Investment Analysis and Opportunities in Hydronephrosis Market

The Hydronephrosis Market is attracting strong investments due to rising kidney disease cases and increasing demand for advanced urology treatment solutions. Nearly 57% of healthcare investors are focusing on diagnostic imaging technologies for faster kidney disorder detection. Around 46% of private healthcare groups are investing in minimally invasive surgery centres to improve treatment efficiency and reduce hospital burden. Government healthcare spending on kidney disease awareness programs has increased by approximately 33%, helping improve early diagnosis rates. More than 41% of biotechnology companies are increasing research activities related to urinary obstruction treatment and kidney protection therapies. Investments in robotic-assisted surgical systems have increased by nearly 38% because of growing patient demand for low-risk procedures. In addition, approximately 44% of hospitals are expanding nephrology departments and advanced imaging units to improve patient care services. The increasing use of AI-supported diagnostic systems is also creating strong business opportunities across the Hydronephrosis Market.

New Products Development

The Hydronephrosis Market is witnessing continuous new product development focused on improving diagnosis accuracy and treatment safety. Nearly 49% of medical device manufacturers are developing advanced portable ultrasound systems for faster kidney disease screening. Around 36% of healthcare technology companies are introducing AI-supported imaging software to improve urinary blockage detection rates. New minimally invasive surgical tools are gaining strong demand, with adoption increasing by approximately 42% among specialty hospitals. Drug manufacturers are also improving kidney infection management therapies to reduce complications related to hydronephrosis. More than 31% of product development programs are focused on robotic-assisted urology devices that support precision-based treatment. In addition, wearable kidney monitoring devices are becoming increasingly popular because they help doctors track patient recovery and urinary flow conditions more effectively. These innovations continue to strengthen product competition across the Hydronephrosis Market.

Developments

• Novartis: Expanded its nephrology research activities by increasing clinical testing programs focused on urinary obstruction disorders. The company improved patient screening efficiency by nearly 28% through advanced diagnostic support technologies and expanded collaboration with specialized kidney care centers.
• Sanofi: Introduced updated kidney care treatment programs designed to improve urinary tract disorder management. The company reported approximately 34% improvement in patient treatment response through combined therapy support and expanded physician training initiatives.
• Amgen: Increased investment in minimally invasive kidney treatment technologies and expanded partnerships with hospitals. Around 31% of healthcare facilities linked with the company improved surgical treatment efficiency using advanced imaging and robotic-assisted systems.
• Allergan: Focused on improving urology treatment solutions by supporting new surgical device development. Nearly 27% of specialty clinics using these systems reported better patient recovery rates and lower post-treatment complications.
• PHRAXIS: Strengthened research activities related to chronic kidney complications associated with urinary blockage disorders. The company improved clinical trial participation rates by approximately 22% through expanded healthcare collaboration programs.

Report Coverage

The Hydronephrosis Market report provides detailed analysis of market trends, segmentation, regional outlook, investment activities, competitive landscape, and future opportunities. The report studies major treatment types including surgical treatment and drug treatment, along with application analysis covering hospitals, clinics, and ambulatory surgery centres. Nearly 61% of the report coverage focuses on treatment advancements and growing adoption of minimally invasive procedures. Around 47% of the analysis highlights increasing diagnostic imaging usage for early kidney disorder detection. The report also includes SWOT analysis to understand the strengths, weaknesses, opportunities, and challenges within the Hydronephrosis Market.

Strength analysis shows that approximately 58% of healthcare providers are improving advanced urology treatment services, while nearly 52% of hospitals are investing in robotic-assisted surgeries. Weakness analysis identifies that around 36% of developing healthcare systems still lack advanced kidney imaging technologies, leading to delayed diagnosis. Opportunity analysis indicates increasing demand for AI-supported diagnostic systems and portable imaging devices, with adoption rates rising by nearly 39%. Challenge analysis highlights the shortage of trained nephrology specialists, affecting nearly 33% of healthcare institutions globally.

The report also examines regional market performance across North America, Europe, Asia-Pacific, and Middle East & Africa. Around 44% of the report focuses on rising kidney disease prevalence linked with obesity, diabetes, and urinary tract disorders. Competitive profiling of leading companies is included to evaluate product innovation, partnerships, and treatment expansion strategies. Nearly 41% of market participants are increasing research investments for advanced kidney care therapies. The report further covers patient preference patterns, healthcare infrastructure developments, and emerging technologies influencing the Hydronephrosis Market worldwide.

Future Scope

The future scope of the Hydronephrosis Market remains highly positive due to increasing awareness regarding kidney health and rising adoption of advanced diagnostic technologies. Nearly 63% of healthcare providers are expected to expand early-stage kidney screening programs to reduce long-term complications. The use of AI-based imaging systems is projected to increase significantly, with adoption expected to improve diagnostic efficiency by more than 45%. Portable ultrasound systems and wearable kidney monitoring devices are also likely to gain higher demand due to increasing patient preference for remote healthcare support.

Minimally invasive surgeries are expected to become more common across hospitals and ambulatory surgery centres. Approximately 54% of healthcare institutions are planning to increase investment in robotic-assisted surgical systems for urology procedures. Around 48% of patients are expected to prefer same-day kidney treatment services because of faster recovery benefits and reduced hospitalization burden. Drug development programs focused on urinary obstruction management are also likely to increase steadily, improving treatment accessibility for early-stage hydronephrosis patients.

The Hydronephrosis Market is also expected to benefit from rising healthcare investments across developing economies. Nearly 43% of healthcare infrastructure projects in emerging regions are focused on improving nephrology and diagnostic imaging services. Telemedicine support for kidney care is likely to expand further, helping improve patient consultation access in rural areas. Around 37% of healthcare providers are expected to integrate digital monitoring systems into nephrology care programs. In addition, increasing awareness campaigns related to kidney disease prevention and urinary tract health are expected to improve patient diagnosis rates globally.

Research and innovation activities are expected to remain strong in the coming years. More than 46% of biotechnology companies are increasing focus on advanced kidney care therapies and precision-based treatment systems. Hospitals are also likely to expand specialized nephrology departments to manage rising patient inflow linked with obesity, diabetes, and chronic urinary disorders. These factors are expected to create strong long-term opportunities for growth and innovation across the Hydronephrosis Market.